Clinical utility of gene-expression profiling for tumor-site origin in patients with metastatic or poorly differentiated cancer: impact on diagnosis, treatment, and survival

PURPOSE: The primary tissue-site origin in over 4% of cancers remains uncertain despite thorough clinicopathological evaluation. This study assessed the effect of a Food and Drug Administration-cleared 2,000-gene–expression-profiling (GEP) test on primary tissue-site working diagnoses and management...

Descripción completa

Detalles Bibliográficos
Autores principales: Nystrom, J. Scott, Hornberger, John C., Varadhachary, Gauri R., Hornberger, Richard J., Gutierrez, Hialy R., Henner, W. David, Becker, Shawn H., Amin, Mahul B., Walker, Michael G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2012
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442294/
https://www.ncbi.nlm.nih.gov/pubmed/22689213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442294/
https://www.ncbi.nlm.nih.gov/pubmed/22689213

Ejemplares similares